Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

Trial Dims Prospects for Rivaroxaban's Cardiovascular Protection in Advanced CKD

Trial Dims Prospects for Rivaroxaban's Cardiovascular Protection in Advanced CKD
ShareXFacebook

(MedPage Today) -- An established blood thinner regimen failed to extend its cardioprotective benefits to patients with advanced chronic kidney disease (CKD), according to the international TRACK trial. In this placebo-controlled study of patients...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Advertisement